Bedside Transcatheter Patent Ductus Arteriosus Device Occlusion in an Extremely Low Birth Weight Neonate: A Novel Approach in a High-Risk Population | Zendy

Tiffany M. Pouldar | Zendy; Robert Wong | Zendy; Myriam Almeida-Jones | Zendy; Evan M. Zahn | Zendy; Lorraine Lubin | Zendy

Open Access

Bedside Transcatheter Patent Ductus Arteriosus Device Occlusion in an Extremely Low Birth Weight Neonate: A Novel Approach in a High-Risk Population

Author(s) -

Tiffany M. Pouldar,

Robert Wong,

Myriam Almeida-Jones,

Evan M. Zahn,

Lorraine Lubin

Publication year - 2021

Publication title -

case reports in anesthesiology

Language(s) - English

Resource type - Journals

eISSN - 2090-6390

pISSN - 2090-6382

DOI - 10.1155/2021/4716997

Subject(s) - medicine , ductus arteriosus , low birth weight , cardiac catheterization , percutaneous , neonatal intensive care unit , occlusion , closure (psychology) , population , pediatrics , intensive care medicine , surgery , pregnancy , genetics , environmental health , economics , market economy , biology

Extremely low birth weight (ELBW) infants weighing less than 1 kilogram are at a high-risk for delayed patent ductus arteriosus (PDA) closure. Percutaneous PDA closure offers a less invasive approach when compared with surgical PDA closure, which may provide faster recovery times and less transfusion requirements. However, this procedure involves transporting tenuous, unstable patients from the neonatal intensive care unit (NICU) to the catheterization laboratory which introduces many potential risks for the neonate. Performing percutaneous PDA closure at the bedside offers a successful alternative to performing the procedure in the catheterization laboratory and avoiding risk associated with transporting ELBW neonates.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research